Work

Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study

Year: 2008

Type: article

Study design: Clinical Trial

Source: Cancer Chemotherapy and Pharmacology

DOI: 10.1007/s00280-007-0672-8

Authors: Jordi Rodon, Mitchell Garrison, Lisa A. Hammond, Johann de Bono, Lon Smith, Leonardo Forero, Desirée Hao, Chris Takimoto, John M. Lambert, Lini Pandite, Maria Howard, Hongsheng Xie, Anthony W. Tolcher

Institutions: Brooke Army Medical Center, ImmunoGen (United States), GlaxoSmithKline (United States)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1977301054

FWCI: 2.304

Cites: 17

Cited by: 37

Related to: 10